延迟支架在老年患者的有效性和安全性 患有STEMI和高血栓负担的老年患者
Ruifang Liu1, Fangxing Xu1, Tongku Liu2
1Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Disease, 100029 Beijing, China.
Reviews in cardiovascular medicine
|July 30, 2024
概括
在患有ST段升高心肌梗塞 (STEMI) 和高血栓负担的老年患者中推迟支架显著减少并发症. 这种方法可以改善心脏功能,是一种安全,有益的治疗策略.
科学领域:
- 心脏病学 心脏病学
- 干预心脏病学 干预心脏病学
- 老年医学 老年医学
背景情况:
- 推迟支架被认为是急性ST段升高心肌梗塞 (STEMI) 与高血栓负担.
- 老年STEMI患者的疗效和安全性需要进一步研究.
- 这项研究解决了老年患者的知识差距.
研究的目的:
- 评估推迟支架在老年STEMI患者高血栓负担的潜在优势.
- 在这个人群中比较推迟和即时支架之间的结果.
主要方法:
- 208名老年患者 (年龄≥80岁) 患有STEMI和高血栓负担被纳入.
- 患者被分为延迟支架 (7-8天抗血栓治疗后支架) 和立即支架组.
- 结果在两组之间进行了比较.
主要成果:
- 推迟支架使用更大的直径,更短的支架 (p<0.05).
- 推迟组中较低的远端栓塞,较高的TIMI和心肌红血3级率 (p<0.05).
- 延期组的1年LVEF率较高,MACE率较低 (p<0.05).
结论:
- 延迟支架为高血栓负担的老年STEMI患者提供了显著的临床益处.
- 这种方法减少了远端栓塞,增强了输液,并保持了心脏功能.
- 延迟支架是安全的,可能是这个群体的首选策略.
相关概念视频
Drug Dosing: Geriatric Patients
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...


